AM, Z., MA, K., DM, E., RM, A., HF, Z., & TM, A. (2026). Investigation of the modulatory effects of fabomotizole and/or sertraline on cisplatin nephrotoxicity via in vivo and in vitro approaches: Insights into the role of Sig-1R/ERK1/2 signaling in regulating mitochondrial dynamics and apoptotic cellular death. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05434-2
Chicago Style (17th ed.) CitationAM, Zaki, Khattab MA, El-Tanbouly DM, Abdelsalam RM, Zaki HF, and Abdelghany TM. "Investigation of the Modulatory Effects of Fabomotizole And/or Sertraline on Cisplatin Nephrotoxicity via in Vivo and in Vitro Approaches: Insights into the Role of Sig-1R/ERK1/2 Signaling in Regulating Mitochondrial Dynamics and Apoptotic Cellular Death." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05434-2.
MLA (9th ed.) CitationAM, Zaki, et al. "Investigation of the Modulatory Effects of Fabomotizole And/or Sertraline on Cisplatin Nephrotoxicity via in Vivo and in Vitro Approaches: Insights into the Role of Sig-1R/ERK1/2 Signaling in Regulating Mitochondrial Dynamics and Apoptotic Cellular Death." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05434-2.